Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (9876)	2/22/2018 9:59:29 AM
From: donpat	Read Replies (1) \| Respond to of 12873

She is a member of Mid Atlantic Bio Angels, a member of AAAS and a board member at the Centre for Molecular Medicine and Therapeutics at the University of British Columbia. MABA Who We Are Mid Atlantic Bio Angels Group Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies. Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels. MABA places no geographical restrictions or requirements for presenting companies, as long as meaningful and effective post-investment monitoring of these companies can be achieved. MABA angels meet monthly (except in the summer) in the New York City area, to hear presentations from companies spanning the entire spectrum of life sciences. Our group follows a multi-step pre-screening process, prior to inviting companies to present to our group. Please visit the "Entrepreneurs" tab to read our investment criteria and to submit an application to our group. If you are an active life science angel investor, and wish to join our group, please visit our Members page. Endeavours MABA maintains an active dialogue with and seeks to invest and share due diligence with other angels and angel groups. In June of 2016 MABA formed a closed-end investment pool (Pool) funded solely by current, active MABA members. The Pool is intended to enable these members to diversify their portfolios by collectively making more frequent, and smaller investments in a greater number of companies (Pool press release). MABA also organizes a series of events called 1st Pitch Life Science to encourage and educate aspiring life science entrepreneurs who know they may be too early to seek investment but want the opportunity to practice their pitch and to receive constructive criticism from experienced and knowledgeable professionals. * * * * * JOIN US bioangels.net Molecular Medicine and Therapeutics at the University of British Columbia. revolvy.com

To: donpat who wrote (9876)	2/22/2018 12:54:24 PM
From: donpat	Respond to of 12873

Licensing Executives Society Concerned By Further Decline in US Patent System Thursday, February 15, 2018 ( 0 Comments) RESTON, VA, FEBRUARY 15, 2018 - The Licensing Executives Society (USA and Canada), Inc. (LES) is deeply concerned by recent evidence of further decline in the effectiveness of the U.S. patent system. On February 8th, the U.S. Chamber of Commerce Global Innovation Policy Center released the 6th edition of its International IP Index. The Index finds that the U.S. patent system has fallen to 12th place in the world. It's lowest ranking in the six years of the history of the Index. This comes after last year's surprising fall from first to 10th place, tied with Hungary. The U.S. Chamber attributes the decline to a "growing level of uncertainty for innovators, particularly in relation to patent protection and technology licensing." The Index specifically cites uncertainties resulting from inconsistent interpretation of Supreme Court attempts to define patent-eligible subject matter by lower courts and the U.S. Patent and Trademark Office. The Index further cites challenges innovators face in post-grant opposition proceedings, which "involve a great deal of cost and lack of predictability for patent owners compared with other post-grant opposition systems." According to LES Past President Brian O'Shaughnessy, "This is all the more disconcerting as LES and its innovation-oriented members have long since pointed to these challenges as compromising our patent system, devaluing innovation, and suppressing new business formation. As goes our patent system, so goes our economy." LES CEO, Kim Chotkowski adds "The cause for concern is still greater in view of Bloomberg's recent report finding that the U.S. has fallen out of the world's top ten innovation-oriented economies, citing similar challenges. Clearly, corrective measures are needed." LES supports legislative and industry efforts to restore the U.S. patent system to its former preeminence. Among these are bills that would remedy the very challenges cited by the Index, including the STRONGER Patents Act (S. 1390). Industry self-regulation will also restore the vitality of our patent and licensing system. Through its Standards Initiative, LES has created a forum, open to all innovation-oriented enterprises, for developing consensus standards in IP-oriented business processes and behavior. These standards will streamline licensing and IP commercialization, and reduce the costs and uncertainties that have contributed to the decline of our patent system. About Licensing Executives Society (U.S.A. and Canada), Inc.: Established in 1965, the Licensing Executives Society, LES, has been a leading association for professionals in the business of intellectual property. Our members evaluate, protect, acquire, sell, license, and enforce IP rights. Our business executives, lawyers, accountants, engineers, scientists, and other experts come from a wide array of startups, multinational corporations, universities, government laboratories, law firms, valuation firms, and other consultancies. Nearly 3000 IP transaction professionals belong to LES (U.S.A. and Canada), and together with 32 other national and regional societies form the membership of the Licensing Executives Society International, totaling nearly 10,000 IP transaction professionals in 90 countries. www.lesusacanada.org. MEDIA CONTACT Kim Chotkowski Chief Executive Officer Phone: (484) 459-1454 Email address: kchotkowski@les.org lesusacanada.org